Efficacy and tolerability of brivaracetam as adjunctive treatment for adults with refractory partial-onset seizures

被引：0
|
作者：
French, J. [1 ]
von Rosenstiel, P. [2 ]
机构：
[1] Univ Penn, Penn Epilepsy Ctr, Philadelphia, PA 19104 USA
[2] UCB Bioprod SA, Braine Lalleud, Belgium
来源：
EPILEPSIA | 2007年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：78 / 78
页数：1
相关论文
共 50 条
  • [1] Efficacy and tolerability of brivaracetam as adjunctive treatment for adults with refractory partial-onset epilepsy
    van Paesschen, W.
    von Rosenstiel, P.
    EPILEPSIA, 2007, 48 : 56 - 57
  • [2] Safety and tolerability of brivaracetam (UCB 34714) as adjunctive treatment in adults with refractory partial-onset seizures
    Brodsky, Antionette
    Costantini, C.
    von Rosenstiel, P.
    EPILEPSIA, 2007, 48 : 342 - 343
  • [3] Brivaracetam: An Adjunctive Treatment for Partial-Onset Seizures
    Kappes, John A.
    Hayes, William J.
    Strain, Joe D.
    Farver, Debra K.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (07): : 811 - 817
  • [4] Efficacy and tolerability of 5, 20 and 50 mg/day brivaracetam (UCB 34714) as adjunctive treatment in adults with refractory partial-onset seizures
    French, J. A.
    Brodsky, A.
    von Rosenstiel, P.
    EPILEPSIA, 2007, 48 : 400 - 400
  • [5] Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial-onset seizures: A phase IIb, randomized, controlled trial
    Van Paesschen, Wim
    Hirsch, Edouard
    Johnson, Martin
    Falter, Ursula
    von Rosenstiel, Philipp
    EPILEPSIA, 2013, 54 (01) : 89 - 97
  • [6] SAFETY AND TOLERABILITY OF LONG-TERM TREATMENT WITH ADJUNCTIVE BRIVARACETAM FOR PARTIAL-ONSET SEIZURES
    Toledo, M.
    Johnson, M. E.
    Whitesides, J.
    Schiemann, J.
    EPILEPSIA, 2015, 56 : 213 - 213
  • [7] Adjunctive brivaracetam for refractory partial-onset seizures A randomized, controlled trial
    French, J. A.
    Costantini, C.
    Brodsky, A.
    von Rosenstiel, P.
    NEUROLOGY, 2010, 75 (06) : 519 - 525
  • [8] Efficacy and tolerability of 50 and 150 mg/day brivaracetam (UCB 34714) as adjunctive treatment in adults with refractory partial-onset epilepsy
    van Paesschen, W.
    Brodsky, A.
    EPILEPSIA, 2007, 48 : 329 - 329
  • [9] RETIGABINE AS ADJUNCTIVE THERAPY IN ADULTS WITH REFRACTORY PARTIAL-ONSET SEIZURES
    French, J.
    Mansbach, H.
    EPILEPSIA, 2009, 50 : 70 - 70
  • [10] Safety, tolerability, and seizure control during long-term treatment with adjunctive brivaracetam for partial-onset seizures
    Toledo, Manuel
    Whitesides, John
    Schiemann, Jimmy
    Johnson, Martin E.
    Eckhardt, Klaus
    McDonough, Belinda
    Borghs, Simon
    Kwan, Patrick
    EPILEPSIA, 2016, 57 (07) : 1139 - 1151
12345